 SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 GLOBE NEWSWIRE -- UNITY Biotechnology, Inc. Nasdaq: UBX, a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that members of its senior management team will participate in the following investor conferences in September. 